Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Antibiotic resistance outbreak ‘could kill 80,000’, report warns

April 7, 2015 Research and Development, Sales and Marketing AMR, Nabriva Therapeutics, antibiotic resistance, bacteria, blood infections, infections

An antibiotic-resistant blood infection outbreak could lead to 80,000 deaths, according to a government report on threats to the UK. …
News

Hundreds of jobs threatened after big pharma deals close

April 7, 2015 Medical Communications, Research and Development, Sales and Marketing Deals, GSK, Jobs, Novartis, US, Valeant, job losses, redundancy, salix

Fresh from deals worth a combined $34 billion, GSK and Salix Pharmaceuticals have announced company restructures that have placed more …
News
Market access means new drugs are available to prescribe to patients

Refining UK market access

April 7, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, UK, health, market access

“Some people have said NICE needs to change, it needs to create a new vision, but we say we need …
Feature
BMS image

BMS enters gene therapy development deal

April 7, 2015 Research and Development BMS, Bristol-Myers Squibb, R&D, cardiovascular disease, cvd, heart disease, heart failure, uniQure

Bristol-Myers Squibb (BMS) has signed a multi-million dollar agreement with Amsterdam-based gene therapy firm uniQure to boost research into new …
News
Merck image

Merck Ebola vaccine safe and effective in latest trials

April 2, 2015 Research and Development, Sales and Marketing Ebola, Merck, National Institutes of Health, VSV-ZEBOV, Vaccine, Walter Reed Army Institute of Research, newlink

Merck and NewLink’s experimental Ebola vaccine has been found to be safe and effective in a new trial in the …
News
Mosquito image

Merck Serono signs antimalarial development deal

April 2, 2015 Research and Development, Sales and Marketing DDD107498, Medicines for Malaria Venture, Merck Serono, antimalarial, malaria

Merck Serono and Medicines for Malaria Venture (MMV) have signed an agreement which will see them advance the development of …
News
Rilutek (riluzole) image

Multiple sclerosis studies underway using existing drugs

April 2, 2015 Research and Development, Sales and Marketing MS, Midamor, Prozac, Rilutek, Sanofi, amiloride, covis, fluoxetine, multiple sclerosis, riluzole

Three existing drugs that fight heart disease, depression and motor neurone disease could be used to treat multiple sclerosis (MS) …
News
Thomas Webb image

Working Life: GlaxoSmithKline’s Thomas Webb

April 2, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Hong Kong, Working Life, macau, oncology, thomas webb

Thomas Webb, launch lead for GSK oncology Hong Kong and Macau How did you find your way into your current role? …
Feature
jonathandancer_1

PM Society appoints two new members

April 2, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing colin williams, jonathan dancer, pm society

Not-for-profit healthcare marketing organisation PM Society has made two new appointments to its executive committee.  Jonathan Dancer (pictured) the managing …
Appointment
Merck image

Merck lines up early-stage Keytruda combo trial

April 1, 2015 Research and Development, Sales and Marketing Cancer, Merck, entinostat, keytruda, pd1, pembrolizumab, syndax

Merck is planning for Keytruda’s future by launching early-stage trials of the drug in combination with an investigational treatment from …
News
charles_mackay_pfizer

Pfizer appoints inflammation and immunology head

April 1, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Charles Reay Mackay, Pfizer

Professor Charles Reay Mackay is joining US pharma giant Pfizer as the chief scientific officer of its inflammation and immunology …
Appointment
Merck Serono image

Merck Serono in $826m immuno-oncology deal

March 31, 2015 Research and Development, Sales and Marketing Intrexon, Merck, Merck Serono, T cell, biopharma, cart, immuno-oncology, t-cell

Merck Serono has announced a significant deal with Intrexon to develop and bring new cancer treatments to market. The German …
News
john_bell

Immunocore appoints key scientist to board

March 31, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing immunocore, john bell

UK biotech Immunocore has appointed the Regius Professor of medicine at Oxford University and chairman of the office for the …
Appointment
Professor John Weinman image

Addressing the adherence gap

March 30, 2015 Research and Development, Sales and Marketing AstraZeneca, Kings College London, Professor John Weinman, adherence

Poor medication use in patients with long-term health conditions is widely recognised as a global problem that urgently needs to …
News

Novartis in major oncology drive

March 30, 2015 Research and Development, Sales and Marketing Cancer, FDA, MHRA, Novartis, aduro, ceritinib, eams, early access, zykadia

Novartis says it is ‘stepping up its efforts’ in cancer by launching major initiatives to discover new treatments to combat …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025